(Q36422010)

14 August 2017

1 reference

title

Herpes simplex virus in immunocompromised patients: growing evidence of drug resistance (English)

1 reference

14 August 2017

Herpes simplex virus in immunocompromised patients: Growing evidence of drug resistance (English)

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

22 October 2022

2

Scully C

1 reference

14 August 2017

J. B. Epstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1653925

22 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1653925

22 October 2022

publication date

1 July 1991

1 reference

full work available at URL

14 August 2017

https://api.elsevier.com/content/article/PII:003042209190188I?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

https://api.elsevier.com/content/article/PII:003042209190188I?httpAccept=text/plain

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Oral surgery, oral medicine, and oral pathology

22 October 2022

published in

1 reference

14 August 2017

72

1 reference

14 August 2017

1

1 reference

14 August 2017

47-50

1 reference

Infections with herpes simplex viruses (1).

14 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Infections with herpes simplex viruses (2).

22 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Antiviral therapy in the immunocompromised patient

22 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Prospective Study of Prevalence, Incidence, and Source of Herpesvirus Infections in Patients with Renal Allografts

22 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Identification of Patients with Increased Risk of Infection with Herpes Simplex Virus after Renal Transplantation

22 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Infection with Herpes Simplex Virus and Cell-Mediated Immunity after Marrow Transplant

22 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

The incidence of oral herpes simplex virus infection in patients undergoing cancer chemotherapy

22 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions

22 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Chronic perianal herpes simplex in immunocompromised hosts

22 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Chronic oral herpes simplex virus infection in immunocompromised patients

22 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Pathogenesis of herpes simplex labialis: excretion of virus in the oral cavity

22 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Pathogenesis of herpes simplex labialis: excretion of virus in the oral cavity

22 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

The role of an immunoperoxidase technique in the diagnosis of oral herpes simplex virus infection in patients with leukemia

22 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection

22 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study

22 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Acyclovir prophylaxis of herpes-simplex-virus infections

22 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Oral mucositis in patients undergoing bone marrow transplantation

22 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

A long-term prospective clinical study of orofacial herpes simplex virus infection in acute leukemia

22 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

A long-term prospective clinical study of oral complications during conventional chemotherapy for acute leukemia

22 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Oral herpes simplex infections in patients with leukemia

22 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Infection with Herpes Simplex Virus and Cell-Mediated Immunity after Marrow Transplant

22 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

22 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial

22 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients

22 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Oral acyclovir prophylactic treatment of herpes simplex infection after bone marrow transplantation

22 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial

22 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Recurrent Infection with Herpes Simplex Virus after Marrow Transplantation: Role of the Specific Immune Response and Acyclovir Treatment

22 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Cancer chemotherapy associated symptomatic stomatitis. Role of herpes simplex virus (HSV)

22 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Prevalence and Incidence of Herpesvirus Infections Among Homosexually Active Men

22 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Otolaryngologic and head and neck manifestations of acquired immunodeficiency syndrome (AIDS).

22 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Infectious and sexually transmitted diseases: implications for dental public health

22 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Oral findings in people with or at high risk for AIDS: a study of 375 homosexual males

22 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Oral findings in patients with acquired immunodeficiency syndrome

22 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Oral manifestations of tumor and opportunistic infections in the acquired immunodeficiency syndrome (AIDS): findings in 53 homosexual men with Kaposi's sarcoma

22 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS.

22 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

A comparative study of herpes simplex infections in renal transplant and leukemic patients

22 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

22 October 2022

Skin infections

39

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Disseminated herpes simplex type 2 and systemic Candida infection in a patient with previous asymptomatic human immunodeficiency virus infection

22 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

The biochemistry and mechanism of action of acyclovir

22 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Effects of long-term acyclovir chemosuppression on serum IgG antibody to herpes simplex virus

22 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Chronic-dose acyclovir to suppress frequently recurring genital herpes simplex virus infection: effect on antibody response to herpes simplex virus type 2 proteins

22 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial

22 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Significance of resistance of herpes simplex virus to acyclovir.

22 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy

22 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir

22 October 2022

49

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed patients

22 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Chronic herpetic infection in an immunocompromised patient: report of a case

22 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?

22 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Virus resistance in clinical practice

22 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child

22 October 2022

54

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

In Vitro Sensitivity to Acyclovir in Genital Herpes Simplex Viruses from Acyclovir-Treated Patients

22 October 2022

55

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir

22 October 2022

56

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Acyclovir resistance in a patient with chronic mucocutaneous herpes simplex infection.

22 October 2022

57

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Characterization of acyclovir-resistant and -sensitive herpes simplex viruses isolated from a patient with an acquired immune deficiency.

22 October 2022

58

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Severe, progressive herpetic whitlow caused by an acyclovir-resistant virus in a patient with AIDS.

22 October 2022

59

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

22 October 2022

60

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Acyclovir-resistant herpes in AIDS treated with foscarnet.

22 October 2022

61

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Herpes simplex virus variants restraint to high concentrations of acyclovir exist in clinical isolates

22 October 2022

62

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Recurrent genital herpes and suppressive oral acyclovir therapy. Relation between clinical outcome and in-vitro drug sensitivity.

22 October 2022

63

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Antiviral effects of phosphonoformate (PFA, foscarnet sodium)

22 October 2022

64

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients

22 October 2022

65

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet)

22 October 2022

66

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

22 October 2022

72

1 reference

https://api.crossref.org/works/10.1016/0030-4220(91)90188-I

22 October 2022

Identifiers

1 reference

14 August 2017

1 reference